CLGM
JAZZ icon

Capitolis Liquid Global Markets’s Jazz Pharmaceuticals JAZZ Stock Holding History

Capitolis Liquid Global Markets’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.75M Hold
28,000
– – 0.03% 228
2026
Q1 		$5.29M Sell
28,000
-32,100
-53% -$5.61M 0.03% 248
2025
Q4 		$10.2M Buy
+60,100
New +$9.21M 0.06% 148

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Capitolis Liquid Global Markets's JAZZ Position: Q2 2026 in Review

Capitolis Liquid Global Markets held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 28,000 shares worth $6.75M. The position accounts for 0.03% of the portfolio, ranked #228.

Capitolis Liquid Global Markets first reported a position in JAZZ in Q4 2025 and has held it in 3 quarters since. The position peaked at $10.2M in Q4 2025. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Capitolis Liquid Global Markets held 28,000 shares of Jazz Pharmaceuticals worth $6.75M as of Q2 2026.
  • Capitolis Liquid Global Markets left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
  • Jazz Pharmaceuticals made up 0.03% of Capitolis Liquid Global Markets's portfolio in Q2 2026, its #228 holding.
  • Capitolis Liquid Global Markets first reported a position in Jazz Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Capitolis Liquid Global Markets's Jazz Pharmaceuticals position peaked at $10.2M in Q4 2025.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q2 2026, filed 13 Aug 2026.